01
Low NADAC$1.33
→
Avg plan cost$2.84
Part D spend $27.8M
2× spread, current vs floor
Class summary at a glance.
Every drug in the mTOR Inhibitor Immunosuppressant class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $27.8Mcombined across class
- Total Rx claims
- 64K15K unique beneficiaries
- Generic mfrs (active)
- 10across all molecules